Focal Vibration for Enhancing Athletic Speed and Ppower
Effectiveness of Focal Vibration in Enhancing Lower Extremity Speed and Power in Athletes
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
A focal vibration device will be used to perform an activation and warm-up protocol before performing a set of 7 repetitions of squat with 60% of your 1RM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2024
CompletedFirst Posted
Study publicly available on registry
November 4, 2024
CompletedStudy Start
First participant enrolled
November 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2024
CompletedNovember 4, 2024
October 1, 2024
25 days
July 25, 2024
October 31, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Mean Speed during squat
A linear transducer (Vitruve VBT) was used to measure the mean speed during the squat. The tether device was attached to the right side of the barbell around the widest part of the collar on the inside and this converts the subject's movement with the barbell into an electrical signal that will record the mean speed and of the exercise. Subjects will per-form 7 repetitions at 0,85 m/s at the maximum possible speed with the optimal load to generate the maximum power. Linear transducers which have greater accuracy (5%) and reliability (ICC: 0.752; 95% CI: 0.548 - 0.855) compared to other devices in terms of velocity-based training (VBT) meas-urement.
1 minute
Mean Power during squat
A linear transducer (Vitruve VBT) was used to measure the mean power during the squat. The tether device was attached to the right side of the barbell around the widest part of the collar on the inside and this converts the subject's movement with the barbell into an electrical signal that will record the mean power of the exercise. Subjects will per-form 7 repetitions at 0,85 m/s at the maximum possible speed with the optimal load to generate the maximum power. Linear transducers which have greater accuracy (5%) and reliability (ICC: 0.752; 95% CI: 0.548 - 0.855) compared to other devices in terms of velocity-based training (VBT) meas-urement.
1 minute
Secondary Outcomes (3)
Scale of perceived effort during squat
1 minute
Participant's rating of clinical change. Global Rating of Change Scale (GROC scale).
1 minute
Muscle Activity
1 minute
Study Arms (2)
Vibration group
EXPERIMENTALThe vibration group receives an intervention with focal vibration heads from Wintecare on the rectus femoris, vastus lateralis and vastus medialis , at the same time that the athelte is doing active muscle contractions.
Sham group
SHAM COMPARATORThe placebo group receives the same protocol but the head of the focal vibration machine is not in contact with the patient's skin.
Interventions
Focal vibration is a 3x3 electrode placed on the athlete's muscle belly, and emits a high frequency vibration (150Hz) to stimulate the muscle spindle and generate greater muscle activation.
Is a focal vibration intervention but without conctact in the athelte's skin. Doing this we got a sham therapy
Eligibility Criteria
You may qualify if:
- Familiarity with the technique and practice of the weighted free squat.
- Training at least 3 times per week.
You may not qualify if:
- Volunteers who have suffered a sports injury during the last two months or are unable to perform physical activity.
- Have previously received an intervention with focal vibration.
- Not understanding the information provided by the therapist.
- Participate in other research studies.
- Be undergoing pharmacological medical treatment that may interfere with the measurements, such as treatment with anticonvulsants, antidepressants, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Msc
Study Record Dates
First Submitted
July 25, 2024
First Posted
November 4, 2024
Study Start
November 5, 2024
Primary Completion
November 30, 2024
Study Completion
December 6, 2024
Last Updated
November 4, 2024
Record last verified: 2024-10